Products - Inflammatory bowel disease | Topic | NICE

Showing 3 products

Date | Title

Status: In developmentRemove ‘Status: In development’ filter

Guselkumab for previously treated moderately to severely active Crohn's disease ID6238
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Guselkumab for treating moderately to severely active ulcerative colitis ID6237
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Mirikizumab for treating moderately to severely active Crohn's disease [ID6244]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC